Revvity Inc (NYSE:RVTY)
$ 116.14 -0.09 (-0.08%) Market Cap: 14.13 Bil Enterprise Value: 16.22 Bil PE Ratio: 56.19 PB Ratio: 1.79 GF Score: 81/100

Revvity Inc at Citi Unplugged Medtech and Life Sciences Access Day Transcript

Feb 29, 2024 / 01:00PM GMT
Release Date Price: $109.59 (+2.09%)
Patrick Bernard Donnelly
Citigroup Inc., Research Division - Senior Analyst

Well, thank you, everybody, for joining us. Excited to have Max from Revvity here. We'll spend about 40 minutes on a fireside chat format. And yes, I'm Patrick Donnelly, the tools and diagnostics analyst here at Citi. So Max, I don't know if you want to give any opening remarks. Maybe we can just -- you guys obviously reported relatively recently. Earnings is somehow still going on for the group. You guys gave a pretty balanced '24 guide, 1Q starting a little slower as is the one in Life Sciences. Maybe you just want to talk about the expectations for the year, and then we can kind of dive into some of the specifics that you walked through.

Maxwell Krakowiak
Revvity, Inc. - Senior VP & CFO

Yes, sure. Thanks for having us, Patrick. I think as you look at -- obviously, just even starting with 2023, I think, obviously, it was a tough year, more challenging than what we had anticipated on the onset of the year. If you look at sort of the trends in what we noticed, really, it was kind

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot